1. Within your health trust how many metastatic breast cancer patients are currently [within the past 6 months] being treated, with any therapy, surgery or palliative care.
A) In the last 6 months 62 metastatic breast cancer patients are currently being treated with anti cancer drugs, palliative care or surgery.
2. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
· disodium pamidronate (Aredia)
· ibandronic acid or ibandronate (Bondronat)
· sodium clodronate (Bonefos, Clasteon, Loron)
· zoledronic acid or zoledronate (Zometa)
· denosumab (Xgeva)
A) Please see below
3. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated with adjuvant therapy with the following treatments;
· disodium pamidronate (Aredia)
· ibandronic acid or ibandronate (Bondronat)
· sodium clodronate (Bonefos, Clasteon, Loron)
· zoledronic acid or zoledronate (Zometa)
A) Please see below
4. Within your health trust how many metastatic lung cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
A) In the last 6 months 110 metastatic lung cancer patients are currently being treated with anti cancer drugs, palliative care or surgery.
5. Within your health trust how many lung cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
· disodium pamidronate (Aredia)
· ibandronic acid or ibandronate (Bondronat)
· sodium clodronate (Bonefos, Clasteon, Loron)
· zoledronic acid or zoledronate (Zometa)
· denosumab (Xgeva)
A) Please see below
6. Within your health trust how many metastatic renal cell cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
A) In the last 6 months 15 metastatic renal cell cancer patients are currently being treated with anti cancer drugs, palliative care or surgery.
7. Within your health trust how many renal cell carcinoma [RCC] patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
· disodium pamidronate (Aredia)
· ibandronic acid or ibandronate (Bondronat)
· sodium clodronate (Bonefos, Clasteon, Loron)
· zoledronic acid or zoledronate (Zometa)
· denosumab (Xgeva)
A) Please see below
RESPONSE FOR Q2,3,5 and 7
Information can not be satisfactorily broken down by condition as this is not recorded on the system. This would take longer than 18 hours to provide as it would require a manual search through patient records. Under section 12 of the Freedom of Information act, we therefore are unable to provide this level of detail. The following data is the total prescribed via the pharmacy system, however this will not take into account any treatments that have been provided from ward stock.
Drug
|
patients
|
disodium pamidronate (Aredia)
|
9
|
ibandronic acid or ibandronate (Bondronat)
|
9
|
sodium clodronate (Bonefos, Clasteon, Loron)
|
0
|
zoledronic acid or zoledronate (Zometa)
|
499
|
denosumab (Xgeva)
|
241
|